Literature DB >> 31102270

Utilization patterns and performance of commercial myositis autoantibody panels in routine clinical practice.

P C Gandiga1,2, J Zhang3, S Sangani1, P Thomas1, V P Werth4,5, M D George1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31102270      PMCID： PMC6824930          DOI： 10.1111/bjd.18133

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  7 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera.

Authors:  Ilaria Cavazzana; Micaela Fredi; Angela Ceribelli; Cristina Mordenti; Fabio Ferrari; Nice Carabellese; Angela Tincani; Minoru Satoh; Franco Franceschini
Journal:  J Immunol Methods       Date:  2016-02-18       Impact factor: 2.303

Review 3.  Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.

Authors:  Jan Damoiseaux; Jean-Baptiste Vulsteke; Chih-Wei Tseng; Anouk C M Platteel; Yves Piette; Ora Shovman; Carolien Bonroy; Dörte Hamann; Ellen De Langhe; Lucille Musset; Yi-Hsing Chen; Yehuda Shoenfeld; Yves Allenbach; Xavier Bossuyt
Journal:  Autoimmun Rev       Date:  2019-01-11       Impact factor: 9.754

4.  TEST performance of a myositis panel in a clinical immunology laboratory in New South Wales, Australia.

Authors:  Teck Choon Tan; Louise Wienholt; Stephen Adelstein
Journal:  Int J Rheum Dis       Date:  2015-12-01       Impact factor: 2.454

Review 5.  Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects.

Authors:  Richard D Sontheimer
Journal:  Dermatol Clin       Date:  2002-07       Impact factor: 3.478

6.  Investigating Idiopathic Inflammatory Myopathy; Initial Cross Speciality Experience with Use of the Extended Myositis Antibody Panel.

Authors:  Antoinette O'Connor; Jennifer Mulhall; Sinead M J Harney; John G Ryan; Grainne Murphy; Michael T Henry; Peter Annis; Vincent Tormey; Aisling M Ryan
Journal:  Clin Pract       Date:  2017-05-04

Review 7.  Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.

Authors:  Z Betteridge; N McHugh
Journal:  J Intern Med       Date:  2015-11-25       Impact factor: 8.989
  7 in total
  2 in total

1.  Accuracy of commercial panels to evaluate myositis autoantibodies: A single-institution perspective.

Authors:  Adarsh Ravishankar; Josef S Concha; Daisy Yan; Christina E Bax; Andrea C Yeguez; Livia Casciola-Rosen; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2020-09-04       Impact factor: 11.527

2.  The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity.

Authors:  Sarah L Tansley; Danyang Li; Zoe E Betteridge; Neil J McHugh
Journal:  Rheumatology (Oxford)       Date:  2020-08-01       Impact factor: 7.580
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.